Drugs / p-ATG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05571332 Background | Jun 2022 → Dec 2023 | aplastic anemia | Institute of Hematology & Blood Diseases Hospital, China | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | p-ATG | “Patients received p-ATG for 5 consecutive days (day 1-5), at a dose of 20 mg/kg/day.” NCT05571332 ↗ |